Logo image of HCWB

HCW BIOLOGICS INC (HCWB) Stock Fundamental Analysis

NASDAQ:HCWB - Nasdaq - US40423R1059 - Common Stock - Currency: USD

0.2782  +0 (+1.24%)

Fundamental Rating

1

Overall HCWB gets a fundamental rating of 1 out of 10. We evaluated HCWB against 572 industry peers in the Biotechnology industry. HCWB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, HCWB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HCWB has reported negative net income.
In the past year HCWB has reported a negative cash flow from operations.
In the past 5 years HCWB always reported negative net income.
HCWB had a negative operating cash flow in each of the past 5 years.
HCWB Yearly Net Income VS EBIT VS OCF VS FCFHCWB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

HCWB has a Return On Assets of -140.57%. This is amonst the worse of the industry: HCWB underperforms 83.36% of its industry peers.
Industry RankSector Rank
ROA -140.57%
ROE N/A
ROIC N/A
ROA(3y)-47.84%
ROA(5y)-53.34%
ROE(3y)-83.53%
ROE(5y)-77.23%
ROIC(3y)N/A
ROIC(5y)N/A
HCWB Yearly ROA, ROE, ROICHCWB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

HCWB's Gross Margin of 32.41% is fine compared to the rest of the industry. HCWB outperforms 75.22% of its industry peers.
The Profit Margin and Operating Margin are not available for HCWB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCWB Yearly Profit, Operating, Gross MarginsHCWB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

HCWB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCWB has been increased compared to 1 year ago.
HCWB has a worse debt/assets ratio than last year.
HCWB Yearly Shares OutstandingHCWB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M
HCWB Yearly Total Debt VS Total AssetsHCWB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -10.50, we must say that HCWB is in the distress zone and has some risk of bankruptcy.
HCWB's Altman-Z score of -10.50 is on the low side compared to the rest of the industry. HCWB is outperformed by 76.46% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.5
ROIC/WACCN/A
WACC9.97%
HCWB Yearly LT Debt VS Equity VS FCFHCWB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

HCWB has a Current Ratio of 0.07. This is a bad value and indicates that HCWB is not financially healthy enough and could expect problems in meeting its short term obligations.
HCWB has a worse Current ratio (0.07) than 98.94% of its industry peers.
HCWB has a Quick Ratio of 0.07. This is a bad value and indicates that HCWB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.07, HCWB is not doing good in the industry: 98.94% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
HCWB Yearly Current Assets VS Current LiabilitesHCWB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for HCWB have decreased strongly by -66.67% in the last year.
Looking at the last year, HCWB shows a very strong growth in Revenue. The Revenue has grown by 22.53%.
Measured over the past years, HCWB shows a very negative growth in Revenue. The Revenue has been decreasing by -11.50% on average per year.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.95%
Revenue 1Y (TTM)22.53%
Revenue growth 3Y-11.5%
Revenue growth 5YN/A
Sales Q2Q%-50.01%

3.2 Future

HCWB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.65% yearly.
HCWB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 141.38% yearly.
EPS Next Y16.94%
EPS Next 2Y9.48%
EPS Next 3Y6.65%
EPS Next 5YN/A
Revenue Next Year368.22%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y141.38%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCWB Yearly Revenue VS EstimatesHCWB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
HCWB Yearly EPS VS EstimatesHCWB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCWB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCWB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWB Price Earnings VS Forward Price EarningsHCWB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCWB Per share dataHCWB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.48%
EPS Next 3Y6.65%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HCWB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HCW BIOLOGICS INC

NASDAQ:HCWB (1/31/2025, 8:00:01 PM)

0.2782

+0 (+1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-01 2024-04-01/amc
Earnings (Next)N/A N/A
Inst Owners3.21%
Inst Owner Change0%
Ins Owners47.77%
Ins Owner Change0%
Market Cap12.39M
Analysts82.86
Price Target3.06 (999.93%)
Short Float %0.53%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)713.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.54
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.08
BVpS-0.22
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -140.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.41%
FCFM N/A
ROA(3y)-47.84%
ROA(5y)-53.34%
ROE(3y)-83.53%
ROE(5y)-77.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 497.64%
Cap/Sales 110.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -10.5
F-Score3
WACC9.97%
ROIC/WACCN/A
Cap/Depr(3y)661.15%
Cap/Depr(5y)472.54%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.95%
EPS Next Y16.94%
EPS Next 2Y9.48%
EPS Next 3Y6.65%
EPS Next 5YN/A
Revenue 1Y (TTM)22.53%
Revenue growth 3Y-11.5%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
Revenue Next Year368.22%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y141.38%
EBIT growth 1Y-73.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.18%
OCF growth 3YN/A
OCF growth 5YN/A